180 related articles for article (PubMed ID: 20193660)
1. Pontine norepinephrine defects in Mecp2-null mice involve deficient expression of dopamine beta-hydroxylase but not a loss of catecholaminergic neurons.
Zhang X; Su J; Rojas A; Jiang C
Biochem Biophys Res Commun; 2010 Apr; 394(2):285-90. PubMed ID: 20193660
[TBL] [Abstract][Full Text] [Related]
2. An optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons.
Zhang S; Johnson CM; Cui N; Xing H; Zhong W; Wu Y; Jiang C
J Neurosci Res; 2016 Oct; 94(10):896-906. PubMed ID: 27317352
[TBL] [Abstract][Full Text] [Related]
3. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.
Viemari JC; Roux JC; Tryba AK; Saywell V; Burnet H; Peña F; Zanella S; Bévengut M; Barthelemy-Requin M; Herzing LB; Moncla A; Mancini J; Ramirez JM; Villard L; Hilaire G
J Neurosci; 2005 Dec; 25(50):11521-30. PubMed ID: 16354910
[TBL] [Abstract][Full Text] [Related]
4. Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice.
Roux JC; Panayotis N; Dura E; Villard L
J Neurosci Res; 2010 May; 88(7):1500-9. PubMed ID: 19998492
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome.
Taneja P; Ogier M; Brooks-Harris G; Schmid DA; Katz DM; Nelson SB
J Neurosci; 2009 Sep; 29(39):12187-95. PubMed ID: 19793977
[TBL] [Abstract][Full Text] [Related]
6. Topographic comparison of the expression of norepinephrine transporter, tyrosine hydroxylase and neuropeptide Y mRNA in association with dopamine beta-hydroxylase neurons in the rabbit brainstem.
Pau KY; Ma YJ; Yu JH; Yang SP; Airhart N; Spies HG
Brain Res Mol Brain Res; 1997 Sep; 48(2):367-81. PubMed ID: 9332734
[TBL] [Abstract][Full Text] [Related]
7. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase a knock out mice.
Zhang J; Darling RD; Paul IA; Simpson KL; Chen K; Shih JC; Lin RC
Anat Rec (Hoboken); 2011 Oct; 294(10):1685-97. PubMed ID: 21901841
[TBL] [Abstract][Full Text] [Related]
9. GABAergic synaptic inputs of locus coeruleus neurons in wild-type and Mecp2-null mice.
Jin X; Cui N; Zhong W; Jin XT; Jiang C
Am J Physiol Cell Physiol; 2013 May; 304(9):C844-57. PubMed ID: 23392116
[TBL] [Abstract][Full Text] [Related]
10. The use of neurotoxins to characterize the rates and subcellular distributions of axonally transported dopamine-beta-hydroxylase, tyrosine hydroxylase and norepinephrine in the rat brain.
Levin BE
Brain Res; 1979 May; 168(2):331-50. PubMed ID: 87244
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice.
Zhang X; Cui N; Wu Z; Su J; Tadepalli JS; Sekizar S; Jiang C
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C635-46. PubMed ID: 20042730
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2.
Kim HS; Hong SJ; LeDoux MS; Kim KS
J Neurochem; 2001 Jan; 76(1):280-94. PubMed ID: 11146001
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II mediates the axonal trafficking of tyrosine hydroxylase and dopamine β-hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons.
Aschrafi A; Berndt A; Kowalak JA; Gale JR; Gioio AE; Kaplan BB
J Neurochem; 2019 Sep; 150(6):666-677. PubMed ID: 31306490
[TBL] [Abstract][Full Text] [Related]
14. Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons: IMPACT ON NEURONAL EXCITABILITY AND BREATHING.
Zhong W; Cui N; Jin X; Oginsky MF; Wu Y; Zhang S; Bondy B; Johnson CM; Jiang C
J Biol Chem; 2015 Jul; 290(30):18400-11. PubMed ID: 25979331
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of catecholamine synthetic enzymes in the caudal ventral pons.
Goodchild AK; Phillips JK; Lipski J; Pilowsky PM
J Comp Neurol; 2001 Oct; 438(4):457-67. PubMed ID: 11559901
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse.
Panayotis N; Pratte M; Borges-Correia A; Ghata A; Villard L; Roux JC
Neurobiol Dis; 2011 Feb; 41(2):385-97. PubMed ID: 20951208
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent modulation of GABA(A)-ergic synaptic transmission by allopregnanolone in locus coeruleus neurons of Mecp2-null mice.
Jin X; Zhong W; Jiang C
Am J Physiol Cell Physiol; 2013 Dec; 305(11):C1151-60. PubMed ID: 24067915
[TBL] [Abstract][Full Text] [Related]
18. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.
Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984
[TBL] [Abstract][Full Text] [Related]
19. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
Kao FC; Su SH; Carlson GC; Liao W
Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
[TBL] [Abstract][Full Text] [Related]
20. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
